FDA approved first seasonal influenza vaccine manufactured using cell culture technology
On Nov. 20, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved first seasonal influenza…
On Nov. 20, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved first seasonal influenza…
On Nov. 15, 2012, the U.S. Centers for Disease Control and Prevention (CDC) responded to the fungal meningitis…
On Nov. 14, 2012, scientists from the U.S., United Kingdom and Germany announced they had completed the first…
On Nov. 8, 2012, Atossa Genetics, the Breast Health Company completed its IPO with gross proceeds of $4…
On Oct. 24, 2012, the Immunization Practices Advisory Committee (ACIP) voted to recommend use of HibMenCY (Menhibrix, GlaxoSmithKline),…
On Oct. 24, 2012, the Immunization Practices Advisory Committee (ACIP) voted 14-0 with one abstention to recommend that…
On Oct. 3, 2012, Takeda Pharmaceutical acquired LigoCyte for an upfront payment of $60 million, with future contingent…
On Sept. 28, 2012, the Connecticut Challenge Survivorship Clinic opened at Yale Cancer Center providing — the first…
On Sept. 19, 2012, Oregon Health & Science University (OHSU) in Portland announced that it had received a…
On Sept. 10, 2012, the Albert and Mary Lasker Foundation announced winners of the annual Lasker Awards: Michael…
On Sept. 10, 2012, Oregon Health Science University (OHSU) announced the estate of Garthe and Grace Brown designated…
On Aug. 30, 2012, a new phlebovirus, discovered in northwestern Missouri by Dr. Scott Folk of Heartland Regional…
On Aug. 10. 2012, Genentech announced that Lucentis (ranibizumab injection) was approved by the U.S. Food and Drug…
On Aug. 3, 2012, GlaxoSmithKline announced that it had completed its acquisition of Human Genome Sciences for $3.6…
On Jul. 31, 2012, the Connecticut Development Authority (CDA) was merged into Connecticut Innovations (CI) which was created…
On Jul. 25, 2012, in a meta-analysis, researchers from the China Medical University in Shenyang and Harvard School…
On Jul. 12, 2012 the University of Kansas Cancer Center earned National Cancer Institute designation. Through efforts initially…
On Jul. 9, 2012, the FDA created the “Breakthrough Therapy Designation” that expedites development and review of drugs…
On Jul. 9, 2012, the National Institutes of Health (NIH) announced it had awarded a $65 million five…
On Jul. 4, 2012, the Serum Institute of India made its first International acquisition by acquiring Bilthoven Biologicals,…
On Jun. 26, 2012, the U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices…
On Jun. 26, 2012, the U.S. Centers for Disease Control and Prevention (CDC) responded to a multi-state outbreak…
On Jun. 26, 2012, Roche announced it had closed the Nutley plant, established in 1929. The Nutley plant…
On Jun. 25, 2012, the Rocky Mountain Biological Laboratory (RMBL) announced the unveiling of its Legacy Campaign, a…
On Jun. 25, 2012, the Helix Center Biotech Incubator opened its doors, owned and operated by the St….
On Jun. 24, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved HibMenCY (Menhibrix, GlaxoSmithKline),…
On Jun. 21, 2012, the European Region of the world was certified as polio-free. Certification followed years of…
On Jun. 15, 2012, Oxford University researchers announced that a knucklebone claimed to be of John the Baptist…
On Jun. 13, 2012, in a project led by the Max Planck Institute for Evolutionary Anthropology in Leipzig,…
On Jun. 13, 2012, the Human Microbiome Project announced the completion of a seminal study of microbial diversity….